Literature DB >> 1802491

Regional intravenous guanethidine blocks in algodystrophy.

F Eulry1, D Lechevalier, B Pats, C Alliaume, P Crozes, P Vasseur, G Coutant, D Felten, S Pattin.   

Abstract

Five-hundred-thirteen regional intravenous guanethidine blocks were carried out in 125 cases of algodystrophy (118 adults), after failure of other treatments in 120 cases (Group I) and without previous treatments in 5 (Group II). A positive result occurred in 85 cases of Group I (71%) and in the 5 cases of Group II, after 4.5 +/- 1.7 blocks. In Group I the results did not differ significantly between upper (33 cases) and lower (87 cases) limb or in regard to sex, age, duration of disease, nature of previous treatments. The presence of psychic disorders was accompanied by less frequent (p less than 0.02) positive results. The tolerance was satisfactory in 85.6% of cases: 22 moderate side effects authorized a continuation of the blocks, 22 serious ones indicated interruption, especially one case of thrombophlebitis and another one of very transitory acute ischaemia. The risk of intolerance was significantly raised (p less than 0.02) by age. The regional guanethidine blocks seemed to be a good treatment for algodystrophy after failure of other treatments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1802491     DOI: 10.1007/BF02206656

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  A case of prolonged hypotension following intravenous guanethidine block.

Authors:  E Sharpe; R Milaszkiewicz; F Carli
Journal:  Anaesthesia       Date:  1987-10       Impact factor: 6.955

2.  [Comparison of treatment with griseofulvin, beta blockers and calcitonin in 55 cases of post-traumatic algoneurodystrophies].

Authors:  L Friez; G Pere; P Breuillard; S Meignan
Journal:  Rev Rhum Mal Osteoartic       Date:  1982-12

3.  Guanethidine after twenty years: a pharmacologist's perspective.

Authors:  R A Maxwell
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

4.  [Vasculitis following guanethidine block treatment in algodystrophy of the foot].

Authors:  B Delcambre; P Cocheteux; F Piette; M Houcke; B Duquesnoy
Journal:  Rev Rhum Mal Osteoartic       Date:  1984 Jul-Sep

5.  The effects of intravenous regional guanethidine and reserpine. A controlled study.

Authors:  C W McKain; B J Urban; J L Goldner
Journal:  J Bone Joint Surg Am       Date:  1983-07       Impact factor: 5.284

Review 6.  Algodystrophy. Reflex sympathetic dystrophy syndrome.

Authors:  P Doury
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

7.  [Treatment of algodystrophies].

Authors:  B Delcambre; B Duquesnoy; G Baudens; P Cocheteux; A Thevenon; J M Delfosse; F Pouyol
Journal:  Rev Rhum Mal Osteoartic       Date:  1982-12

8.  Pain relief following post-ganglionic sympathetic blockade with I.V. guanethidine.

Authors:  C J Glynn; R W Basedow; J A Walsh
Journal:  Br J Anaesth       Date:  1981-12       Impact factor: 9.166

9.  Regional intravenous guanethidine vs. stellate ganglion block in reflex sympathetic dystrophies: a randomized trial.

Authors:  S Bonelli; F Conoscente; P G Movilia; L Restelli; B Francucci; E Grossi
Journal:  Pain       Date:  1983-07       Impact factor: 6.961

10.  [Regional intravenous guanethidine for sympathetic block in algodystrophic syndromes (author's transl)].

Authors:  J M Farcot; P Mangin; B Laugner; J B Thiebaut; G Foucher
Journal:  Anesth Analg (Paris)       Date:  1981
View more
  3 in total

1.  Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate.

Authors:  B Cortet; R M Flipo; P Coquerelle; B Duquesnoy; B Delcambre
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

Review 2.  Reflex sympathetic dystrophy.

Authors:  E Paice
Journal:  BMJ       Date:  1995-06-24

3.  Treatment of complex regional pain syndrome type I of the hand with a series of intravenous regional sympathetic blocks with guanethidine and lidocaine.

Authors:  Kosmas I Paraskevas; Alexandra A Michaloglou; Despina D Briana; Maria Samara
Journal:  Clin Rheumatol       Date:  2005-12-07       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.